1-(2-nitrobenzoyl)-3-[4-(pyrimidin-2-yloxy)phenyl]urea | 112283-18-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(2-nitrobenzoyl)-3-[4-(pyrimidin-2-yloxy)phenyl]urea
• 英文别名: 2-nitro-N-((4-(pyrimidin-2-yloxy)phenyl)carbamoyl)benzamide；2-nitro-N-[(4-pyrimidin-2-yloxyphenyl)carbamoyl]benzamide
• CAS: 112283-18-8
• 化学式: C₁₈H₁₃N₅O₅
• 分子量: 379.332
• InChiKey: IECHAQGBUKOBHA-UHFFFAOYSA-N

物化性质

• 密度：
  1.461±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  28
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  139
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  1-(2-nitrobenzoyl)-3-[4-(pyrimidin-2-yloxy)phenyl]urea 在 铁粉 、 溶剂黄146 作用下， 反应 0.5h， 生成 2-amino-N-((4-(pyrimidin-2-yloxy)phenyl)carbamoyl)benzamide
  参考文献：
  名称：

  Benzoylphenylurea Sulfur Analogues with Potent Antitumor Activity

  摘要：

  A novel series of BPU analogues were synthesized and evaluated for antitumor activity. In particular, BPU sulfur analogues 6n and 7d were shown to possess up to10-fold increased potency, when compared to I (NSC-639829), against cancer cell lines. 6n was more effective than I in causing apoptosis of MCF-7 cells. When compared to other drugs with a similar mechanism of action, 6n retained significant ability to inhibit tubulin assembly, with an IC50 of 2.1 mu M.

  DOI：

  10.1021/jm051261s
• 作为产物：
  描述：

  对氨基苯酚 在 potassium carbonate 作用下， 以 1,4-二氧六环 、 二甲基亚砜 为溶剂， 反应 20.5h， 生成 1-(2-nitrobenzoyl)-3-[4-(pyrimidin-2-yloxy)phenyl]urea
  参考文献：
  名称：

  Benzoylphenylurea Sulfur Analogues with Potent Antitumor Activity

  摘要：

  A novel series of BPU analogues were synthesized and evaluated for antitumor activity. In particular, BPU sulfur analogues 6n and 7d were shown to possess up to10-fold increased potency, when compared to I (NSC-639829), against cancer cell lines. 6n was more effective than I in causing apoptosis of MCF-7 cells. When compared to other drugs with a similar mechanism of action, 6n retained significant ability to inhibit tubulin assembly, with an IC50 of 2.1 mu M.

  DOI：

  10.1021/jm051261s

文献信息

• [EN] hTERT MODULATORS AND METHODS OF USE<br/>[FR] MODULATEURS HTERT ET PROCÉDÉS D'UTILISATION
  申请人：UNIV ARIZONA

  公开号：WO2017095969A1

  公开（公告）日：2017-06-08

  The present invention provides hTERT modulators and methods for producing and using the same. In particular, the present invention provide a compound of the formula as described herein. Some aspects of the invention are based on the characterization of the effect of hTERT core promoter region mutants on the 5-12 G-quadruplex structure and its stability. It is believed that some of the compounds of the invention bind selectively to the G-quadruplex in the hTERT core promoter mutant, which results in reversal of the effect of mutant promoter activation.

  本发明提供hTERT调节剂及其生产和使用方法。具体来说，本发明提供了如下所述的一种化合物。该发明的一些方面基于对hTERT核心启动子区域突变体对5-12 G-四链结构及其稳定性影响的表征。据信，本发明的一些化合物选择性地结合到hTERT核心启动子突变体中的G-四链结构，从而逆转突变启动子激活的效果。
• hTERT modulators and methods of use
  申请人：Arizona Board of Regents on Behalf of the University of Arizona

  公开号：US10556860B2

  公开（公告）日：2020-02-11

  The present invention provides hTERT modulators and methods for producing and using the same. In particular, the present invention provide a compound of the formula as described herein. Some aspects of the invention are based on the characterization of the effect of hTERT core promoter region mutants on the 5-12 G-quadruplex structure and its stability. It is believed that some of the compounds of the invention bind selectively to the G-quadruplex in the hTERT core promoter mutant, which results in reversal of the effect of mutant promoter activation.

  本发明提供了 hTERT 调节剂及其生产和使用方法。特别是，本发明提供了如本文所述的式化合物。本发明的某些方面基于 hTERT 核心启动子区突变体对 5-12 G-四链结构及其稳定性影响的表征。据信，本发明的某些化合物可选择性地与 hTERT 核心启动子突变体中的 G-四叉体结合，从而逆转突变体启动子激活的效应。
• hTERT MODULATORS AND METHODS OF USE
  申请人：The Arizona Board of Regents On Behalf of the University of Arizona

  公开号：EP3383841A1

  公开（公告）日：2018-10-10
• US7595326B2
  申请人：——

  公开号：US7595326B2

  公开（公告）日：2009-09-29
• Benzoylphenylurea Sulfur Analogues with Potent Antitumor Activity
  作者：Gurulingappa Hallur、Antonio Jimeno、Susan Dalrymple、Tao Zhu、M. Katherine Jung、Manuel Hidalgo、John T. Isaacs、Saraswati Sukumar、Ernest Hamel、Saeed R. Khan

  DOI：10.1021/jm051261s

  日期：2006.4.1

  A novel series of BPU analogues were synthesized and evaluated for antitumor activity. In particular, BPU sulfur analogues 6n and 7d were shown to possess up to10-fold increased potency, when compared to I (NSC-639829), against cancer cell lines. 6n was more effective than I in causing apoptosis of MCF-7 cells. When compared to other drugs with a similar mechanism of action, 6n retained significant ability to inhibit tubulin assembly, with an IC50 of 2.1 mu M.